CD13 Antigens [antigeny CD13]
- Terms
-
alaninaminopeptidasa
alaninaminopeptidáza
aminooligopeptidasa
aminopeptidáza M
aminopeptidáza N
antigen CD13
protein ANPEP
-
Alanine Aminopeptidase
Alanyl Aminopeptidase
Amino-oligopeptidase
Aminooligopeptidase
Aminopeptidase M
Aminopeptidase N
ANPEP Protein
Antigens, CD13
CD13 Antigen
Membrane Alanyl Aminopeptidase
Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.
- DUI
- D018826 MeSH Browser
- CUI
- M0028180
- Previous indexing
- Antigens, Differentiation (1988); Alanine (1975-1980); Aminopeptidases (1981-1994); Antigens, CD (1991-1994); Antigens, Differentiation, Myelomonocytic (1989-1994)
- History note
- 2018 (1975)
- Public note
- 2018; see ANTIGENS, CD13 1995-2017, CD13 ANTIGEN 1988-94, and ALANINE AMINOPEPTIDASE 1975-94; CD13 ANTIGENS was indexed under ANTIGENS, CD 1991-94; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; and ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 and under ALANINE 1975-80
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- AI
- antagonists & inhibitors 1
- BI
- biosynthesis 1
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 2
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
H11 protein, Haemonchus contortus Chemical MeSH Browser